CompletedNot Applicable

Study of Arterial Recanalization of the Central Retinal Artery Occlusions

France80 participantsStarted 2016-12-23

Plain-language summary

Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the retinal level. They share the same risk factors and common pathology. Their incidence is lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual acuity (VA) \<1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no data on early retinal arterial recanalization after CRAO, nor on the relationship between early recanalization (spontaneous or post-thrombolysis) and visual prognosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Central Retinal Artery Occlusion ≤ 24 hours Exclusion Criteria: * Retinal Dynamic angiography not performed within 48 hours of onset of symptoms * Occlusion of a branch of the central retinal artery

What they're measuring

Dynamic retinal angiography data at 24 hours (+/- 24 hours)

Timeframe: 24 hours (+/- 24 hours) following the beginning of symptoms

Trial details

NCT IDNCT03049514

SponsorFondation Ophtalmologique Adolphe de Rothschild

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2022-04-02

View on ClinicalTrials.gov More Central Retinal Artery Occlusion trials